- Conditions
- Fragile X Syndrome
- Interventions
- MG01CI extended-release tablet
- Drug
- Lead sponsor
- Alcobra Ltd.
- Industry
- Eligibility
- 15 Years to 55 Years
- Enrollment
- 62 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 11
- States / cities
- Phoenix, Arizona • Sacramento, California • Aurora, Colorado + 8 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- ADHD, Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type
- Interventions
- MG01CI (1400 mg), placebo
- Drug
- Lead sponsor
- Alcobra Ltd.
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 18
- States / cities
- Gainesville, Florida • South Miami, Florida • Libertyville, Illinois + 15 more
- Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
- Interventions
- MDX, Placebo
- Drug
- Lead sponsor
- Alcobra Ltd.
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 283 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2017
- U.S. locations
- 36
- States / cities
- Dothan, Alabama • Los Alamitos, California • Newport Beach, California + 32 more